4//SEC Filing
Ullman Anders 4
Accession 0001104659-21-102886
CIK 0001657312other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:41 PM ET
Size
5.8 KB
Accession
0001104659-21-102886
Insider Transaction Report
Form 4
Ullman Anders
Director
Transactions
- Award
Share Options (Right to Buy)
2021-08-09+64,000→ 64,000 totalExercise: $0.78Exp: 2031-08-08→ Ordinary Shares (64,000 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The option vests and becomes exercisable as to 25% on August 9, 2021, 25% on November 1, 2021, 25% on February 1, 2022 and 25% on May 1, 2022.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0001836816
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:41 PM ET
- Size
- 5.8 KB